Results 251 to 260 of about 143,588 (347)

Molecular Interplay of PARN and Telomerase: Tail Modifiers and Disease Implications

WIREs RNA, Volume 17, Issue 4, July/August 2026.
Schematic representation of the molecular interplay between PARN, telomerase‐associated, and the involvement of p53 in regulating telomere maintenance and genome stability. The top panel shows how normal PARN levels are involved in regulating p53 levels and balanced telomerase activity through their regulatory interaction with TERC and TERRA, thus ...
Sujitha Felicitus, Shalon Suzanne Pinto, Sai Samanvitha Madagundapalli Ramakrishna, Dechamma Pandyanada Nanjappa, Gunimala Chakraborty, Anirban Chakraborty   +5 more
wiley   +1 more source

Opportunistic Screening of High-Risk Breast Cancer Variants in Hospital Biobank Setting. [PDF]

Cancer Epidemiol Biomarkers Prev
Pehrsson M, Jakkula E, Ala-Kulju K, Loukola A, Niemelä J, Löfman K, Anttonen AK, Meretoja T, Mattson J, Lappalainen M, Pöyhönen M, Carpén O.   +11 more
europepmc   +1 more source

BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma

Thoracic Cancer, Volume 17, Issue 13, July 2026.
We evaluated whether BAP1 loss is associated with clinical outcomes following immunotherapy. BAP1 loss shows better progression‐free survival (PFS), but we can't conclude that BAP1 loss is a favorable predictive biomarker. The reason is that BAP1 loss may have a better baseline prognosis, and it is necessary to consider the interactions with other ...
Reina Imase, Rie Sakakibara, Susumu Kirimura, Hironori Ishibashi, Kenichi Okubo, Yasunari Miyazaki   +5 more
wiley   +1 more source

Single-cell RNA sequencing reveals immune microenvironment heterogeneity in BRCA1-mutated and sporadic triple-negative breast cancer. [PDF]

Transl Oncol
Sun Q, Zhong Y, Sun C.
europepmc   +1 more source

Engineering Extracellular Vesicles for Anti‐Aging Therapy: Mechanisms, Applications, and Perspectives

Aging Cell, Volume 25, Issue 7, July 2026.
This review systematically elucidates the multifactorial anti‐aging mechanisms of extracellular vesicles (EVs). By bridging fundamental biology with advanced bioengineering, scalable manufacturing, and clinical translation, it establishes a comprehensive framework for developing next‐generation EVs‐based precision nanotherapeutics to combat systemic ...
Xian Huang, Qiujie Li, Guofang Tao, Xulin Gan, Jiangjie Lu, Sergei Krasny, Liyun Shi   +6 more
wiley   +1 more source

BRCA1 and Rb? [PDF]

Breast Cancer Research, 1999
openaire   +1 more source

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Background: BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of breast cancers (BCs) in men with BRCA1/2 mutations.
Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE), Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Pujana Genestar, M. Ángel, KConFab Investigators   +3 more
core  

Current Status and Challenges of <i>BRCA1</i> and <i>BRCA2</i> Genetic Testing for Hereditary Breast and Ovarian Cancer in Japan. [PDF]

Cancer Diagn Progn
Onishi K, Horimoto Y, Kiribayashi K, Koyama Y, Orimoto K, Uenaka N, Kusama H, Kawate T, Yamada K, Kaise H, Inagaki N, Ishikawa T.   +11 more
europepmc   +1 more source

Malignant craniopharyngiomas: Institutional experience and literature review

Brain Pathology, Volume 36, Issue 4, July 2026.
We report the second case of malignant craniopharyngioma with BAP1 and TP53 mutations. A literature review identified 44 cases of malignant craniopharyngiomas with a median overall survival of 6 months. Eighteen (41%) occurred in patients without any history of radiation, suggesting that mechanisms other than radiation have contributed to their ...
Thomas J. Auen, Isabella W. Zhang, Weiwei Zhang, Jordan M. Burr, Matthew L. Carda, James L. Wisecarver, Nicole Shonka, Jesse L. Cox, Sahara J. Cathcart, Allison Cushman‐Vokoun, Jie Chen   +10 more
wiley   +1 more source

Simultaneous Risk-Reducing Mastectomy and Salpingo-Oophorectomy in Patients with <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants: A Single-Center Retrospective Cohort Study. [PDF]

J Pers Med
Diaz R, Murelli F, Alessandri F, Centurioni MG, Barra F, Cuniolo L, Allievi R, Saad A, Cornacchia C, Depaoli F, Margarino C, Ponzielli L, Bertulla E, Boccardo C, Baldelli I, Leone MS, Adami M, Franchelli S, Pesce M, Trevisan L, Fregatti P.   +20 more
europepmc   +1 more source